Austin biopharma startup Shattuck Labs files to go public

Austin is on the cusp of adding another publicly traded biopharmaceutical company. Shattuck Labs filed Sept. 18 for an initial public offering on the Nasdaq with the ticker "STTK." No date or share price has been announced yet. The offering size is proposed as $100 million, although that's likely a placeholder amount. The public S-1 filing comes a little more than a month after Shattuck filed confidentially on Aug. 7, according to Nasdaq. A clinical-stage biotechnology company, Shattuck works…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news